Casey Means, President Donald Trump’s nominee for U.S. Surgeon General, has faced significant obstacles in her confirmation process, ultimately leading to the withdrawal of her nomination after more than a year of deliberations. Means, a Stanford graduate and co-author of the book "Good Energy," was nominated in May 2025 following the withdrawal of a previous candidate. Despite early support from Health Secretary Robert F. Kennedy Jr., who praised her as an articulate advocate for his health agenda, Means encountered sustained resistance from Senate members and questions about her qualifications and positions on key health issues.
The nomination process was marked by delays and procedural complexities. Although nominated in early May, Means’s paperwork was not submitted to the Senate until June and only reached the Senate Health Committee in September, after ethics and background checks raised concerns. At that time, Means was seven months pregnant, and the committee initially scheduled a virtual confirmation hearing for late October, coinciding with her due date. She went into labor on the day of the hearing, forcing a postponement until February 2026.
During the rescheduled hearing, Means emphasized her focus on chronic diseases but faced intense questioning, especially from Republicans, about her stance on vaccines. While she acknowledged that vaccines save lives, Means stopped short of pledging to recommend measles and influenza immunizations for children and declined to categorically deny a link between vaccines and autism. These responses, coupled with ongoing scrutiny of her medical license and ethics paperwork, contributed to growing skepticism among senators.
Key Republican senators, including Lisa Murkowski of Alaska and Susan Collins of Maine, emerged as pivotal voices in opposing the nomination. Means made last-ditch efforts to gain their support, including phone conversations shortly before the confirmation vote, but faced persistent questions about her personal vaccination choices. She described some inquiries as inappropriate, particularly when asked about her infant son’s immunization status. Both senators’ offices declined to comment extensively on the discussions.
Internal White House communications revealed ambivalence regarding Means’s confirmation timeline. Early in the process, some White House staff appeared reluctant to expend political capital on her nomination, particularly amid her pregnancy. However, after Health Secretary Kennedy intervened, the administration pushed for a hearing, underscoring her alignment with the administration’s goals to "deliver on the MAHA (Make America Healthy Again) agenda" and promote what they termed "Gold Standard Science" in health policymaking.
Despite strong advocacy from Kennedy and other MAHA supporters, the nomination stalled amid bipartisan concerns and alleged political maneuvering. Kennedy publicly criticized Senate Health Committee Chairman Bill Cassidy (R., La.) for obstructing the confirmation, a claim Cassidy’s office did not publicly address. The Senate Health Committee later stated it was clear that Means lacked the necessary votes for confirmation.
On March 2, 2026, with no apparent path forward in the Senate, President Trump announced a new nominee for surgeon general, ending Means’s protracted confirmation battle. The episode has highlighted divisions within the Senate regarding vaccine policy and the role of the surgeon general as a public health authority. It also exposed tensions within the White House over managing the confirmation amid the broader political implications of the MAHA agenda.